Neil Evans Washington, DC
Leveraging elements of the Agilex Mobile Health Platform, Agilex will work with VA to integrate VistA with popular mobile devices, such as the Apple iOS (iPhone and iPad) platform. By doing so, it will provide clinicians with on-demand access to a patient’s medical history, including demographics, laboratory data, medications, allergies, appointments, and problem lists. The project will also integrate clinical calendars and secure messaging with the devices to streamline scheduling and information exchange. Another key focus will be on addressing device security to achieve compliance with federal and VA directives.
CRN Healthcare Informatics
Agilex is also a leader in bringing enterprise mobility solutions to government. The company’s enterprise mobility services include strategy and visioning, program management, solution and application development, system engineering, testing, configuration management, training and customer support. The Agilex Mobile Health Platform is an integrated solution for creating, operating and supporting enterprise healthcare applications spanning multiple mobile devices in a secure and sustainable manner.
Agilex is an Apple Authorized Systems Integrator. This recently launched program identifies IT services providers certified by Apple to deliver enterprise solutions based on Apple technology. Agilex’ certification encompasses iPad® and iPhone® devices, the Macintosh® computing platform and Apple® software.
VAi2 is a VA-wide program designed to encourage and foster innovative solutions to the most significant challenges facing Veterans. The award to improve patient care was given to Agilex as part of the Industry Innovation Competition, which was VA’s third competition to date and the first to involve the private sector.
About Agilex Technologies, Inc.
Realize the Value of Information
Chantilly, Virginia Washington Business Journal Washington, DC Fastest Growing Company 2010 Hottest Emerging Government Contractor Washington, DC
SOURCE Agilex Technologies, Inc.